Literature DB >> 34549319

Chronic inflammation and long-lasting changes in the gastric mucosa after Helicobacter pylori infection involved in gastric cancer.

Hang Yang1, Bin Wei2, Bing Hu3.   

Abstract

OBJECTIVE: Helicobacter pylori (H. pylori) infects approximately half of the world's population, as one of the most common chronic infections. H. pylori infection has been widely recognized as a major risk factor for gastric cancer (GC).
METHODS: Eradication treatment is considered to abolish the inflammatory response and prevent progression to GC. However, only 1-3% of H. pylori-infected patients develop GC, whereas GC can occur even after eradicating H. pylori. In addition, the incidence of GC following H. pylori infection is significantly higher compared to the gross incidence induced by all causes, although eradicating H. pylori reduces the risk of developing GC.
RESULTS: Therefore, it is reasonable to hypothesize that H. pylori infection results in changes that persist even after its eradication. Several of these changes may not be reversible within a short time, including the status of inflammation, the dysfunction of immunity and apoptosis, mitochondrial changes, aging and gastric dysbacteriosis.
CONCLUSION: The present review article aimed to discuss these potential long-lasting changes induced by H. pylori infection that may follow the eradication of H. pylori and contribute to the development of GC.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Aging; Apoptosis; Gastric cancer; Gastric dysbacteriosis; Helicobacter pylori; Mitochondria

Mesh:

Year:  2021        PMID: 34549319     DOI: 10.1007/s00011-021-01501-x

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  131 in total

1.  Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Authors:  P Malfertheiner; F Megraud; C A O'Morain; J P Gisbert; E J Kuipers; A T Axon; F Bazzoli; A Gasbarrini; J Atherton; D Y Graham; R Hunt; P Moayyedi; T Rokkas; M Rugge; M Selgrad; S Suerbaum; K Sugano; E M El-Omar
Journal:  Gut       Date:  2016-10-05       Impact factor: 23.059

2.  Family History of Gastric Cancer and Helicobacter pylori Treatment.

Authors:  Il Ju Choi; Chan Gyoo Kim; Jong Yeul Lee; Young-Il Kim; Myeong-Cherl Kook; Boram Park; Jungnam Joo
Journal:  N Engl J Med       Date:  2020-01-30       Impact factor: 91.245

Review 3.  Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis.

Authors:  James K Y Hooi; Wan Ying Lai; Wee Khoon Ng; Michael M Y Suen; Fox E Underwood; Divine Tanyingoh; Peter Malfertheiner; David Y Graham; Vincent W S Wong; Justin C Y Wu; Francis K L Chan; Joseph J Y Sung; Gilaad G Kaplan; Siew C Ng
Journal:  Gastroenterology       Date:  2017-04-27       Impact factor: 22.682

4.  Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus.

Authors:  Jyh-Ming Liou; Peter Malfertheiner; Yi-Chia Lee; Bor-Shyang Sheu; Kentaro Sugano; Hsiu-Chi Cheng; Khay-Guan Yeoh; Ping-I Hsu; Khean-Lee Goh; Varocha Mahachai; Takuji Gotoda; Wei-Lun Chang; Mei-Jyh Chen; Tsung-Hsien Chiang; Chieh-Chang Chen; Chun-Ying Wu; Alex Hwong-Ruey Leow; Jeng-Yih Wu; Deng-Chyang Wu; Tzu-Chan Hong; Hong Lu; Yoshio Yamaoka; Francis Megraud; Francis K L Chan; Joseph Jy Sung; Jaw-Town Lin; David Y Graham; Ming-Shiang Wu; Emad M El-Omar
Journal:  Gut       Date:  2020-10-01       Impact factor: 23.059

5.  Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years.

Authors:  Y-J Hwang; N Kim; H S Lee; J B Lee; Y J Choi; H Yoon; C M Shin; Y S Park; D H Lee
Journal:  Aliment Pharmacol Ther       Date:  2017-11-29       Impact factor: 8.171

6.  A Possible Link between Gastric Mucosal Atrophy and Gastric Cancer after Helicobacter pylori Eradication.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Noriyuki Horiguchi; Tomohiko Kawamura; Masaaki Okubo; Takamitsu Ishizuka; Mitsuo Nagasaka; Yoshihito Nakagawa; Naoki Ohmiya
Journal:  PLoS One       Date:  2016-10-05       Impact factor: 3.240

7.  Characteristics of Primary and Metachronous Gastric Cancers Discovered after Helicobacter pylori Eradication: A Multicenter Propensity Score-Matched Study.

Authors:  Yuji Maehata; Shotaro Nakamura; Motohiro Esaki; Fumie Ikeda; Tomohiko Moriyama; Risa Hida; Ema Washio; Junji Umeno; Minako Hirahashi; Takanari Kitazono; Takayuki Matsumoto
Journal:  Gut Liver       Date:  2017-09-15       Impact factor: 4.519

8.  Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication.

Authors:  Susumu Take; Motowo Mizuno; Kuniharu Ishiki; Chiaki Kusumoto; Takayuki Imada; Fumihiro Hamada; Tomowo Yoshida; Kenji Yokota; Toshiharu Mitsuhashi; Hiroyuki Okada
Journal:  J Gastroenterol       Date:  2019-10-30       Impact factor: 7.527

9.  Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands.

Authors:  Hsiu-Hsi Chen; Yi-Chia Lee; Tsung-Hsien Chiang; Wei-Jung Chang; Sam Li-Sheng Chen; Amy Ming-Fang Yen; Jean Ching-Yuan Fann; Sherry Yueh-Hsia Chiu; Yi-Ru Chen; Shu-Ling Chuang; Chun-Fu Shieh; Cheng-Ying Liu; Han-Mo Chiu; Hung Chiang; Chia-Tung Shun; Ming-Wei Lin; Ming-Shiang Wu; Jaw-Town Lin; Chang-Chuan Chan; David Y Graham
Journal:  Gut       Date:  2020-08-13       Impact factor: 23.059

10.  The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood.

Authors:  Seiichi Kato; Toshiaki Shimizu; Shigeru Toyoda; Benjamin D Gold; Shinobu Ida; Takashi Ishige; Shigeru Fujimura; Shigeru Kamiya; Mutsuko Konno; Kentaro Kuwabara; Kosuke Ushijima; Norikazu Yoshimura; Yoshiko Nakayama
Journal:  Pediatr Int       Date:  2020-12       Impact factor: 1.524

View more
  1 in total

1.  Comparable genetic alteration profiles between gastric cancers with current and past Helicobacter pylori infection.

Authors:  Sho Tsuyuki; Hideyuki Takeshima; Shigeki Sekine; Yukinori Yamagata; Takayuki Ando; Satoshi Yamashita; Shin Maeda; Takaki Yoshikawa; Toshikazu Ushijima
Journal:  Sci Rep       Date:  2021-12-06       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.